1-2 of 2
Rebecca Mathew
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

iBRIDGE: A Data Integration Method to Identify Inflamed Tumors from Single-cell RNA-Seq Data and Differentiate Cell Type–Specific Markers of Immune-Cell Infiltration

Open Access
Tolga Turan, Sarah Kongpachith, Kyle Halliwill, Robert T. McLaughlin, Mikhail Binnewies, Dhemath Reddy, Xi Zhao, Rebecca Mathew, Shiming Ye, Howard J. Jacob, Josue Samayoa
Journal: Cancer Immunology Research
Cancer Immunol Res (2023) 11 (6): 732–746.
https://doi.org/10.1158/2326-6066.CIR-22-0283
Published: 02 June 2023
View articletitled, iBRIDGE: A Data Integration Method to Identify Inflamed Tumors from Single-cell RNA-Seq Data and Differentiate Cell Type–Specific Markers of Immune-Cell Infiltration
Open the PDF for iBRIDGE: A Data Integration Method to Identify Inflamed Tumors from Single-cell RNA-Seq Data and Differentiate Cell Type–Specific Markers of Immune-Cell Infiltration in another window
Includes: Supplementary data
Journal Articles

Abstract A41: Small molecule inhibition of PTPN2/1 inflames the tumour microenvironment and unleashes potent CD8+ T cell immunity

Free
Hakimeh Ebrahimi-Nik, Arvin Iracheta-Vellve, Kira E. Olander, Thomas R.G. Davis, Sarah Y. Kim, Mitchell D. Yeary, James C. Patti, Tyler M. Balon, Omar Ismail Avila, Cun Lan Chuong, Meng-Ju Wu, Christina K. Baumgartner, Keith M. Hamel, Kathleen A. McGuire, Rebecca Mathew, Carey Backus, Ian C. Kohnle, Zhaoming Xiong, Elliot P. Farney, Jennifer M. Frost, Geoff T. Halvorsen, Matthew Rees, Andrew Boghossian, Melissa Ronan, Jennifer A. Roth, Todd R. Golub, Gabriel K. Griffin, Nabeel El-Bardeesy, Clay C. Beauregard, Philip R. Kym, Kathleen B. Yates, Robert T. Manguso
Journal: Cancer Immunology Research
Cancer Immunol Res (2022) 10 (12_Supplement): A41.
https://doi.org/10.1158/2326-6074.TUMIMM22-A41
Published: 01 December 2022
View articletitled, Abstract A41: Small molecule inhibition of PTPN2/1 inflames the tumour microenvironment and unleashes potent CD8+ T cell immunity